News Releases


05 September 2019
Cronos Group Inc. Closes Redwood Holding Group Acquisition
TORONTO , Sept. 05, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”) today announced that it has closed its previously announced acquisition of four Redwood Holding Group, LLC operating subsidiaries.
Read More








News Releases

05 September 2019
Cronos Group Inc. Closes Redwood Holding Group Acquisition
TORONTO , Sept. 05, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”) today announced that it has closed its previously announced acquisition of four Redwood Holding Group, LLC operating subsidiaries.
08 August 2019
Cronos Group Inc. Announces Second Quarter and First-Half 2019 Results
Opened Cronos Device Labs , New Global R&D Center in Israel Appointed Dr. Todd Abraham as Chief Innovation Officer Announced Agreement to Acquire State-of-the-Art Fermentation Facility Established New Growth Opportunity in the United States with Acquisition of Hemp-Based Products Platform  TORONTO
09 July 2019
Cronos Group Appoints Dr. Todd Abraham as Chief Innovation Officer
36-Year CPG Executive Brings Extensive Experience in Identifying, Developing and Commercializing Breakthrough Technology for Consumer Goods Sector TORONTO , July 09, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”) today announced that Dr.
08 July 2019
Cronos Group Inc. to Hold Second Quarter 2019 Earnings Conference Call
TORONTO , July 08, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc.  (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”), will announce its financial results for the second quarter ended June 30, 2019, and hold its Second Quarter 2019 Earnings Conference Call on Thursday, August 8,
19 June 2019
Cronos Group Inc. Announces Results of Vote for Election of Directors
TORONTO , June 19, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”) reports that at its Annual Meeting of Shareholders on June 19, 2019 there were 610 shareholders voting in person or by proxy holding in total 261,290,314 common shares,
29 May 2019
Cronos Group Inc. Sets Date for 2019 Annual Meeting of Shareholders
TORONTO , May 29, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”), an innovative global cannabinoid company, will hold its 2019 Annual Meeting of Shareholders on Wednesday, June 19, 2019 at 10 a.m.
14 May 2019
Cronos Group and MediPharm Labs Enter Cannabis Concentrate Supply Agreement
Cronos Group and MediPharm Labs Enter Additional Multi-Year Tolling Arrangement  TORONTO , May 14, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”), is pleased to announce that it has entered into a multi-year supply agreement with
09 May 2019
Cronos Group Inc. Announces First Quarter 2019 Results
Cronos Group Closes C$2.4 Billion Strategic Investment from Altria Group Cronos Group Establishes Cronos Device Labs , a State-of-the-Art Vaporizer R&D Initiative NatuEra Receives License to Cultivate Psychoactive Cannabis in Colombia Spinach™ Partners with Arrive Alive DRIVE SOBER® Cronos Group
07 May 2019
Cronos Group Opens Cronos Device Labs, New Global R&D Center in Israel
Accelerates Efforts to Develop Next-Generation Vaporizer Products Designed Specifically for Cannabinoids TORONTO , May 07, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”) today announced that it is expanding its global infrastructure
08 March 2019
Cronos Group Inc. Closes C$2.4 Billion Strategic Growth Investment from Altria Group, Inc.

TORONTO , March 08, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced that the C$2.4 billion equity investment in the Company by Altria Group, Inc. (NYSE: MO) (“Altria”) has closed. As previously announced, Altria’s investment represents an approximate 45% ownership interest in Cronos Group . Altria also has a warrant to acquire additional ownership in Cronos Group , which is exercisable over the next four years. If exercised in full today, the warrant would increase Altria’s ownership in Cronos Group to approximately 55% and provide Cronos Group with additional proceeds of approximately C$1.4 billion .

04 March 2019
Cronos Group Inc. Exits Investment in Whistler Medical Marijuana Corporation
TORONTO , March 04, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“ Cronos Group ” or the “ Company ”), confirmed today that it has sold all of its common shares in the capital of Whistler Medical Marijuana Corporation (" Whistler "), representing approximately 19 percent
23 January 2019
Cronos Group Inc. Announces Closing of $65 Million Credit Facility
TORONTO , Jan. 23, 2019 /PRNewswire/ - Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (" Cronos Group " or the " Company ") today announced that it has entered into a credit agreement (the " Credit Agreement ") with Canadian Imperial Bank of Commerce (" CIBC "), as administrative agent and



Print Page Sign Up for Email Alerts RSS Feeds Financial Tearsheet